Could a blood test predict Alzheimer's disease 16 years before symptoms?

In a 405-person clinical trial, Quanterix's technology was able to detect upticks on a potential biomarker as much as 16 years before the participant began showing symptoms.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.